Summary:
We are currently recruiting subjects with acne who are between 12-45 years old. This study investigates the effectiveness and safety of an investigational injectable subcutaneous treatment.
The study drug consists of an injectable subcutaneous investigational treatment or a placebo (with no active treatment), that will be administered once on Day 1, and then monthly for 2 months.
During the study visits, a physical evaluation of the acne and overall health will be done by the study team. Several blood samples as well as tape strips (a non-invasive surface collection of skin) will be collected throughout the study. Facial photography will be conducted at each study visit while photographs of upper body if applicable are optional.
This study will last a period of up to 5.5 months and includes up to 7 visits. Visits take approximately 1 hour on average. Day 1 may take up to 7 hours and the screening visit may take up to 3 hours.
Compensation for travel may be available. There will be no cost to you (or your child) for taking part in this study. You (or your child) will be provided with all study medication, examinations and medical care related to the study at no cost to you.
Qualified Participants Must:
• 1. Facial IGA score of 3 (moderate) or 4 (severe)
•
2. At least 20 and no more than 100 inflammatory lesions on the face
•
3. No more than 100 noninflammatory lesions on the face
•
4. No more than 5 nodules (5 mm or bigger) on the face
Qualified Participants May Receive:
Screening $ 150
Day 1 $ 150
Day 15 $150
Day 29 $150
Day 57 $150
Day 87 $ 150
Day 141 $150
a total of $1050